Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin prophylaxis for infection prevention after impacted mandibular third molar extraction
ACTRN12617001498381Phase 4Completed
- Sponsor
- Universidad de Chile
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of amoxicillin in surgical site infection (SSI) and alveolar osteitis (AO) (2 arms), sponsored by Universidad de Chile. Primary endpoints: Alveolar osteitis at 30 days, Surgical site infection at 30 days and 1 more. Started May 2016; status: completed.
02
Drugs
amoxicillin
03
Conditions
surgical site infection (SSI)alveolar osteitis (AO)
Beyond the preview
Go deeper on ACTRN12617001498381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001498381.